Johan Stenberg
Corporate Officer/Principal bei University of Uppsala
Profil
Johan Stenberg is the founder of two companies, Halo Genomics AB founded in 2008 and Q-linea AB founded in 2008.
At Q-linea AB, he also held the title of Senior Application Scientist from 2009 to 2012.
Currently, Dr. Stenberg is a Principal at the University of Uppsala.
He received his undergraduate degree from Stanford University and his graduate and doctorate degrees from the University of Uppsala.
Aktive Positionen von Johan Stenberg
| Unternehmen | Position | Beginn |
|---|---|---|
| University of Uppsala | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Johan Stenberg
| Unternehmen | Position | Ende |
|---|---|---|
Halo Genomics AB
 Halo Genomics AB Medical/Nursing ServicesHealth Services Halo Genomics AB operates as a genomics company. It offers sample preparation solutions to provide scientists with enabling tools to analyze the genetic foundation of disease. The firm provides reagent kits and a service for the multiplex amplification of exons for targeted re-sequencing that includes selector probe library design and synthesis, target regions amplification, and quality control of the enrichment. The company was founded by Olle Ericsson in 2008 and is headquartered in Uppsala, Sweden. | Gründer | - |
| Q-LINEA AB | Gründer | - |
Ausbildung von Johan Stenberg
| University of Uppsala | Doctorate Degree |
| Stanford University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| Q-LINEA AB | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Halo Genomics AB
Halo Genomics AB Medical/Nursing ServicesHealth Services Halo Genomics AB operates as a genomics company. It offers sample preparation solutions to provide scientists with enabling tools to analyze the genetic foundation of disease. The firm provides reagent kits and a service for the multiplex amplification of exons for targeted re-sequencing that includes selector probe library design and synthesis, target regions amplification, and quality control of the enrichment. The company was founded by Olle Ericsson in 2008 and is headquartered in Uppsala, Sweden. | Health Services |
